Cardinal Capital Management Integra Lifesciences Holdings Corp Transaction History

Cardinal Capital Management

$631 Million
Q3 2024

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$23.14 - $34.72 $68,610 - $102,944	2,965 Added 9.54%	34,034 $991,000
Q1 2024 Jul 12, 2024	BUY	$33.4 - $45.2 $299,531 - $405,353	8,968 Added 40.58%	31,069 $1.1 Million
Q1 2024 Apr 15, 2024	BUY	$33.4 - $45.2 $299,531 - $405,353	8,968 Added 40.58%	31,069 $1.1 Million
Q4 2023 Jul 12, 2024	BUY	$34.21 - $44.59 $11,870 - $15,472	347 Added 1.6%	22,101 $962,000
Q4 2023 Jan 26, 2024	BUY	$34.21 - $44.59 $11,870 - $15,472	347 Added 1.6%	22,101 $962,000
Q3 2023 Jul 12, 2024	BUY	$37.8 - $45.97 $27,858 - $33,879	737 Added 3.51%	21,754 $830,000
Q3 2023 Oct 16, 2023	BUY	$37.8 - $45.97 $27,858 - $33,879	737 Added 3.51%	21,754 $830,000
Q2 2023 Jul 12, 2024	SELL	$37.95 - $58.98 $381,473 - $592,866	-10,052 Reduced 32.35%	21,017 $864,000
Q2 2023 Jul 12, 2023	BUY	$37.95 - $58.98 $15,104 - $23,474	398 Added 1.93%	21,017 $864,000
Q1 2023 Apr 18, 2023	BUY	$52.61 - $60.49 $2,262 - $2,601	43 Added 0.21%	20,619 $1.18 Million
Q4 2022 Jan 20, 2023	BUY	$42.17 - $58.6 $30,952 - $43,012	734 Added 3.7%	20,576 $0
Q3 2022 Oct 21, 2022	BUY	$42.28 - $57.17 $30,737 - $41,562	727 Added 3.8%	19,842 $841,000
Q2 2022 Aug 04, 2022	BUY	$53.86 - $66.52 $24,075 - $29,734	447 Added 2.39%	19,115 $1.03 Million
Q1 2022 Apr 21, 2022	BUY	$62.86 - $69.24 $57,265 - $63,077	911 Added 5.13%	18,668 $1.2 Million
Q4 2021 Jan 18, 2022	BUY	$62.47 - $73.25 $937 - $1,098	15 Added 0.08%	17,757 $1.19 Million
Q3 2021 Oct 21, 2021	BUY	$64.97 - $76.19 $5,847 - $6,857	90 Added 0.51%	17,742 $1.22 Million
Q2 2021 Jul 14, 2021	SELL	$66.79 - $76.63 $3,473 - $3,984	-52 Reduced 0.29%	17,652 $1.21 Million
Q1 2021 Apr 19, 2021	BUY	$62.63 - $71.15 $8,204 - $9,320	131 Added 0.75%	17,704 $1.22 Million
Q4 2020 Feb 01, 2021	BUY	$43.31 - $66.55 $16,197 - $24,889	374 Added 2.17%	17,573 $1.14 Million
Q3 2020 Oct 16, 2020	BUY	$43.33 - $51.72 $23,008 - $27,463	531 Added 3.19%	17,199 $812,000
Q2 2020 Jul 16, 2020	BUY	$41.42 - $55.57 $39,597 - $53,124	956 Added 6.08%	16,668 $783,000
Q1 2020 Apr 20, 2020	SELL	$36.67 - $61.04 $60,175 - $100,166	-1,641 Reduced 9.46%	15,712 $701,000
Q4 2019 Jan 21, 2020	SELL	$55.73 - $62.49 $19,338 - $21,684	-347 Reduced 1.96%	17,353 $1.01 Million
Q3 2019 Oct 18, 2019	SELL	$53.29 - $64.59 $2,611 - $3,164	-49 Reduced 0.28%	17,700 $1.06 Million
Q2 2019 Jul 08, 2019	SELL	$46.45 - $55.85 $11,008 - $13,236	-237 Reduced 1.32%	17,749 $991,000
Q1 2019 Apr 11, 2019	BUY	$42.97 - $57.33 $3,738 - $4,987	87 Added 0.49%	17,986 $1 Million
Q4 2018 Jan 15, 2019	BUY	$42.62 - $64.51 $12,231 - $18,514	287 Added 1.63%	17,899 $807,000
Q3 2018 Oct 25, 2018	BUY	$57.63 - $65.87 $1,844 - $2,107	32 Added 0.18%	17,612 $1.16 Million
Q2 2018 Jul 25, 2018	BUY	$54.05 - $67.23 $2,432 - $3,025	45 Added 0.26%	17,580 $1.13 Million
Q1 2018 Apr 25, 2018	SELL	$46.55 - $57.38 $6,656 - $8,205	-143 Reduced 0.81%	17,535 $970,000
Q4 2017 Feb 01, 2018	SELL	$46.22 - $51.77 $8,412 - $9,422	-182 Reduced 1.02%	17,678 $846,000
Q3 2017 Oct 24, 2017	BUY	$47.8 - $53.63 $853,708 - $957,831	17,860	17,860 $901,000

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$249 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$172 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$116 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$93.4 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$87.9 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Account